SurModics (SRDX) Tops Q4 EPS by 15c

Go back to SurModics (SRDX) Tops Q4 EPS by 15c

SurModics (SRDX) PT Lowered to $70 at Needham & Company

November 10, 2021 12:10 PM EST

Needham & Company analyst Mike Matson lowered the price target on SurModics (NASDAQ: SRDX) to $70.00 (from $76.00) while maintaining a Buy rating.

The analyst commented, "SRDX's F4Q21 revenue and EPS beat consensus. Initial FY22 revenue and EPS guidance was well below consensus... More